The US bill provides for more research on psychedelic mushrooms

Representatives from the state Oklahomato us AmericaPassed bill to allow medical researchers to investigate Psychedelic mushrooms for Treatment of mental illness. The House approved by a vote of 66 to 32.

PL 2107 develops faculties and research facilities and examines their effects Psilocybin Oklahoma residents struggle with conditions like obsessive-compulsive disorder and treatment-resistant depression. A Psilocybin is a psychological combination of Mushrooms.

At Thursday’s hearing, critics said the measure was not fiscally responsible and that Oklahoma should have allowed other states to take the lead in the vote. Others have said it opens the door to widespread use Medicines And it can be dangerous.

The measure has already been approved by the House Committee on Alcohol, Tobacco and Controlled Substances. The approved measure now heads to the Oklahoma State Senate.

Rep. Daniel Bay, a Lawton Republican who authored the bill, said it’s a national conversation because it’s about research, it’s about saving lives, and it’s about addressing the mental health crisis our nation faces. he told the inquest.

What is the new size?

The act states that a university or research center can conduct scientific research and clinical trials Psilocybin For the treatment of patients 18 years of age and older:

• post-traumatic stress disorder;
• treatment-resistant/refractory depression;
• treatment-resistant/refractory anxiety;
• treatment-resistant/refractory obsessive-compulsive disorder;
• head injury;
• early stage dementia;
• Prophylactic treatment;
• end-of-life care;
• opioid use disorder;
• Moderate to severe chronic pain.

Some studies are going on by scientists Johns Hopkins University, which houses a psychedelic research facility. The unit found that patient assisted therapy Mushrooms Can reduce stress for up to a year.

Source: ByteWriting